Study: Methylphenidate Use Benefits Daily Functioning, Performance at Work
September 17, 2026
Methylphenidate (brand name: Ritalin) use is associated with real-time improvements in both ADHD symptoms and daily functioning at work, which continue to strengthen over time in adults with ADHD, according to a new exploratory study published in the Journal of Attention Disorders.1
Of participants with ADHD who received methylphenidate:
- 39.6% showed improvement in both symptoms and functioning
- 33.8 % showed improvement in symptoms but not functioning
- 4.3% showed improvement in functioning but not symptoms
Within the placebo group, symptoms and functioning improved in 26% of participants, and 43.8% demonstrated no improvement on either measure.
The findings suggest that evaluating symptom improvement alone isn’t enough to determine whether a patient is receiving optimal treatment. Clinicians should also consider how ADHD medication impacts a patient’s daily functioning, such as their ability to arrive at work on time, perform job functions reliably, and meet productivity goals at work.
“The evaluation of symptoms alone may be a relatively weak method of determining if a patient is actually being optimally treated,” the study’s authors wrote. “Symptom change may be more immediate and more sensitive to medication treatment, but robust symptom change is associated with the functional response that is the more meaningful target of treatment.”
The study included a four-week double-blind clinical trial followed by a six-month open-label (OL) follow-up phase. The researchers measured symptoms and functional changes before and after the study period using the ADHD Rating Scale-5 (ADHD-5-RS), the Clinical Global Impressions Improvement scale (CGI-I), and the Weiss Functional Impairment Rating Scale—Self Report (WFIRS-S). (The WFIRS-S evaluates how the patient feels their emotional and behavioral symptoms impact their level of functioning in the following domains: Family, Work, School, Life Skills, Self-Concept, Social, and Risky Activities.)
For the clinical trial, 351 adults with ADHD aged 18 and older took extended-release methylphenidate ranging from 25 mg to 100 mg or placebo once daily. At the end of the four weeks, 40% of those taking methylphenidate showed significant functional improvement, and 47.5% were rated as “improved” or “very much improved” on the CGI-I. Symptoms continued to improve, with 14% of improvement occurring in the last four months of the six-month OL phase.
Clinicians titrated methylphenidate doses to the point of optimal improvement during the OL phase. By the sixth month, 66.7% of the 124 participants achieved both symptomatic and functional improvement across all WFIRS-S domains.
Stimulant Treatment Associated with Improvements in Job Performance
Work was the only WFIRS-S domain in which participants taking methylphenidate showed significant improvements compared with the placebo group during the double-blind clinical trial and the OL follow-up. (The Work domain assessed job performance, punctuality, job retention, productivity, and work potential.)
The association between methylphenidate treatment and improved work-related functioning may offer hope for adults with ADHD, who face a substantially higher risk of career instability and unemployment.2, 3
In 2024, a longitudinal study of nearly 7,000 participants in the Journal of Attention Disorders found that individuals with comorbid ADHD and oppositional defiant disorder symptoms face higher unemployment rates, lower overall income, and more frequent sick days in adulthood compared to their neurotypical peers.4
Many ADDitude readers have experienced firsthand how ADHD symptoms can impact employment status and job performance.
“I have lost plenty of jobs due to my ADHD symptoms,” wrote Tim, from North Carolina. “However, I was unmedicated for many years and didn’t realize that I was struggling because of my ADHD.”
“I left my most recent job because I couldn’t handle all the details in the paperwork,” said Dawn from Virginia. “I just kept missing things. It wasn’t a good fit.”
“I suffered from severe burnout from a job that wasn’t suited for my ADHD brain,” another reader said. “It resulted in severe exhaustion and depression and became so serious that I lost the ability to continue employment. I’ve been surviving on disability benefits since.”
While more research is needed to determine which parts of an adult’s daily life respond best to stimulants, and how doctors can fine-tune ADHD medication doses for each patient, the study’s authors are encouraged by their findings.
“The take-home message for clinicians is that stimulant treatment of adults with ADHD can be anticipated to lead to functional improvement in most patients and optimized functional impairment over time in more than half of patients,” they wrote.
Sources
1Weiss, M.D., Newcorn, J.H., Donnelly, G.A.E. et al. (2026). An exploratory study of functional outcome in stimulant treatment of ADHD in adults. Journal of Attention Disorders. https://doi.org/10.1177/10870547261440452
2 Jangmo, A., Kuja-Halkola, R., Pérez-Vigil, A., et al. (2021). Attention-deficit/hyperactivity disorder and occupational outcomes: the role of educational attainment, comorbid developmental disorders, and intellectual disability. PLoS One. https://doi.org/10.1371/journal.pone.0247724
3Jervan, B., Torgersen, T., Nordahl, H.M., & Rasmussen, K. (2012). Functional impairment and occupational outcome in adults with ADHD. J Atten Disord. https://doi.org/10.1177/1087054711413074
4 Seppä, S., Huikari, S., Korhonen, M., Nordström, T., Hurtig, T., & Halt, A.-H. (2024). Associations of symptoms of ADHD and oppositional defiant disorder (ODD) in adolescence with occupational outcomes and incomes in adulthood. Journal of Attention Disorders. https://doi.org/10.1177/10870547241259329